Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
Craniale radiotherapie bij acute lymfatische leukemie leidt tot hersenschade later
apr 2017 | Leukemie, Radiotherapie